Introduction
============

Epilepsy is a chronic, non-communicable disorder of the brain that could affect people of any age. Approximately 50 million people worldwide have epilepsy, making it one of the most common neurological diseases globally.[@b1-ppa-12-2111] Most seizures can be controlled with antiepileptic drugs (AEDs). Surgery to remove the epileptogenic lesion may also stop seizure activity. A ketogenic (high-fat, low-carbohydrate) diet may be used to treat epilepsy (recurrent seizures) in children, particularly if seizure medicines are not effective.[@b2-ppa-12-2111]

CAM is sought by PWE as an alternative treatment option although its effectiveness has not been clearly established using scientific methods. CAM can be defined as "a broad domain of healing resources that encompasses all health systems, modalities, and practices, and their accompanying theories and beliefs, other than those intrinsic to the politically dominant health systems of a particular society or culture in a given historical period".[@b3-ppa-12-2111] CAM is reported to be used worldwide.[@b4-ppa-12-2111]--[@b6-ppa-12-2111] In various Asian and African countries, CAM is the primary method of health care.[@b7-ppa-12-2111] Over the last decade, the interest in CAM has increased rapidly.[@b8-ppa-12-2111]

Based on the National Center for Complementary and Alternative Medicine (NCCAM, 2005), CAMs are broadly divided into five types: biological, spiritual/mind-body, alternative, physical (body-based), and energy therapies.[@b9-ppa-12-2111] Biological methods, also known as natural products, include herbs, vitamins, dietary supplements, antioxidants, and minerals while mind and body practices include acupuncture, aromatherapy, cupping, massage, prayer for health (use of holy water, amulets, or talismans) and Zumba. Alternative medicine includes traditional medicines that vary from region to region, eg, traditional Chinese, Malay, Indian (Ayurvedic/Siddha/Unani) medicines and homeopathy.[@b9-ppa-12-2111],[@b10-ppa-12-2111]

The use of CAMs may vary due to differences in cultural norms and healthcare settings. A study performed in Malaysia demonstrated that 71.2% of respondents admitted to CAM use and the use of herbal products was the most popular CAM. The main reason for CAM use was recommendations from family and friends.[@b11-ppa-12-2111]

Medication adherence or the older term, drug compliance, is defined as the extent to which patients follow the instructions they are given for prescribed treatments, and their persistence in completing the duration of time from initiation to discontinuation of therapy.[@b12-ppa-12-2111] Usually, measurements of medication adherence are classified by the WHO as subjective and objective measurements.[@b13-ppa-12-2111] Subjective measurements include those requiring the patient's evaluation of their medication-taking behavior. Self-reported questionnaires, eg, MMAS, and healthcare professional assessments are the most common tools used to assess medication adherence.[@b14-ppa-12-2111] Objective measures include pill counts, secondary database analysis such as the MPR, electronic monitoring, and biochemical measures.[@b15-ppa-12-2111] According to the WHO, the prevalence of AED adherence in developing countries ranges between 20% and 80%.[@b16-ppa-12-2111] In Malaysia, the prevalence of poor adherence to AEDs was documented in 64.1% of PWE, which is higher than the percentages reported in studies conducted in western populations.[@b17-ppa-12-2111]

The four primary factors related to medication non-adherence are patient-related factors (eg, socioeconomic characteristics, and perceptions and beliefs), illness-related factors (eg, severity of illness and frequency of symptoms), medication-related factors (eg, number of daily doses, efficacy, and side effects), and physician-related factors (eg, patient-physician relationship).[@b18-ppa-12-2111]--[@b21-ppa-12-2111] In a study performed in Malaysia, a busy lifestyle, forgetfulness, younger age, adverse effects of drugs, and limited contact time with a physician were identified as factors affecting adherence.[@b17-ppa-12-2111]

Medication non-adherence is a serious issue in PWE and the belief that epilepsy has a spiritual or psychological cause may contribute to inadequate AED therapy and higher dependence on CAM, which can result in AED non-adherence. There is inadequate data on the impact of CAM on adherence among PWE. The purpose of this study was to determine the use pattern and impact of CAM on AED adherence among PWE.

Methods
=======

Studies were identified through a comprehensive literature search of Scopus, Ovid, Medline, Science Direct, Google Scholar, and PubMed from the inception of these sources until May 2018. The keywords used for searching for relevant articles were "adherence," "compliance," "AED," "epilepsy," "non-adherence," "CAM," and "complementary and alternative medicine." Boolean operators such as 'AND' and 'OR' were used to increase the sensitivity and specificity of the search when needed. The articles identified were then screened based on the inclusion and exclusion criteria presented in [Table 1](#t1-ppa-12-2111){ref-type="table"}. Initial titles/abstracts were screened by MJF. The exclusion process, using the title/abstract, was also performed by MJF if the reason for exclusion was clear. If there was uncertainty, the article was not excluded and was reviewed by MMB. Any disagreements on whether a study should be included/excluded were resolved through consensus. Data were extracted from a full-text report using a data extraction form, which included study characteristics, participant characteristics, rate of medication adherence, and adherence assessment methods. The primary outcomes of the current study were the rate of patients' adherence to AEDs, CAM use, and impact of CAM on AED adherence. The quality of the studies was assessed for potential bias by using the evaluation tool for quantitative research studies.[@b22-ppa-12-2111]

Results
=======

A total of 3,330 titles were retrieved and of this 93 were removed due to duplication. The remaining articles were screened for inclusion and exclusion criteria. Thirty studies were included in the final review. [Figure 1](#f1-ppa-12-2111){ref-type="fig"} shows the flow of study identification.

Of the 30 studies, 16 focused on CAM usage among PWE, 13 reported medication adherence, and only one investigated CAM usage and patients' adherence to AEDs. The types of study design and country settings have been summarized in [Tables 2](#t2-ppa-12-2111){ref-type="table"}[](#t3-ppa-12-2111){ref-type="table"}[](#t4-ppa-12-2111){ref-type="table"}--[5](#t5-ppa-12-2111){ref-type="table"}.

Prevalence and types of CAM usage
---------------------------------

In the 16 papers identified, the prevalence of CAM use was between 7.5% and 73.3%. The use of CAM in developed countries was higher than that in the developing countries. However, the types of CAM used did not differ much, with some variation due to differences in cultural and traditional norms. The most prevalent type of CAMs reported in these studies were herbal (n=6), prayer/spirituality (n=5), and yoga/exercise (n=5).

The belief that epilepsy has a spiritual or psychological cause, rather than being a primary ailment of the brain contributes to inadequate AED therapy and higher dependence on CAM, which results in inadequate AED treatment.[@b23-ppa-12-2111]

In developed countries, CAM treatments are frequently used for overall wellness or for chronic conditions, for instance, epilepsy or pain, that respond inadequately to standard treatments.[@b24-ppa-12-2111] In Western Europe and North America, regardless of availability and accessibility to advanced technology and evidence-based allopathic medicine, CAM is expanding in terms of its economic importance as a treatment choice for many health care needs.[@b25-ppa-12-2111] In most of the studies performed in the USA, yoga, botanicals (herbs), prayer/spirituality, vitamins, and stress reduction were the most frequently used methods in PWE.[@b8-ppa-12-2111],[@b26-ppa-12-2111],[@b27-ppa-12-2111] Majority of the patients did not disclose the use of CAM to their doctors.[@b8-ppa-12-2111],[@b28-ppa-12-2111] In one survey among PWE in the USA, the most commonly used herbs were ginseng, St John's wort, ginkgo (*Ginkgo biloba*), and garlic.[@b29-ppa-12-2111] These results were consistent with those of a study that showed that garlic and ginkgo were most frequently used by PWE.[@b30-ppa-12-2111]

Use of amulets, prayer for health, and visits to faith healers were common among Islamic countries.[@b31-ppa-12-2111]--[@b34-ppa-12-2111] Some types of CAM are more specific to a region and may vary between countries. The use of Ayurvedic medicine has been reported in several studies in India.[@b35-ppa-12-2111]--[@b37-ppa-12-2111] In Taiwan, traditional Chinese medicine is quite prevalent since it was established in China about 3,000 years ago.[@b38-ppa-12-2111] The Taiwanese have been greatly influenced by Chinese culture. Many Taiwanese believe that worship can cure an illness.[@b39-ppa-12-2111] The prevalence and types of CAM used in developed and developing countries are summarized in [Table 2](#t2-ppa-12-2111){ref-type="table"}.

### Factors and reasons associated with CAM use

Among 16 papers identified, only eight papers reported the reasons for CAM use. The most commonly reported factors included fear of AED-related side effects (n=4)[@b31-ppa-12-2111],[@b33-ppa-12-2111]--[@b36-ppa-12-2111],[@b40-ppa-12-2111] and poor seizure control (n=3).[@b28-ppa-12-2111],[@b39-ppa-12-2111],[@b40-ppa-12-2111] Two studies reported the influence of family members as the reason for CAM usage.[@b35-ppa-12-2111],[@b40-ppa-12-2111]

It is worthwhile to note that patients attributed their epilepsy to factors outside the realm of a biomedical model, including spirit possession (Jinn), evil eyes, contemptuous envy, or sorcery.[@b32-ppa-12-2111],[@b41-ppa-12-2111] Therefore, it seems consistent that most people adhere to a holistic perspective or to scriptural teaching (Holy Qur'an) as a health aid to their epilepsy. In addition to being a health aid, it is possible that CAM is used to reduce social stigma. For example, in Oman, the presence of hyper salivation and belief in spirits as the causes of epilepsy were strong predictors of CAM use.[@b34-ppa-12-2111]

### Prevalence of medication non-adherence among PWE

The prevalence of non-adherence in 13 studies ranged between 25% and 66% as shown in [Figure 2](#f2-ppa-12-2111){ref-type="fig"}. The overall adherence level in western countries was higher than that in Asian counties. This reflects that people living in developing countries prefer traditional medicines to modern allopathic medicines, which may lead to non-adherence.

Many adherence calculation methods were used across the included studies.[@b42-ppa-12-2111]--[@b45-ppa-12-2111] The MMAS was used in four surveys.[@b44-ppa-12-2111]--[@b47-ppa-12-2111] Two studies used the MMAS-4 tool and two studies used the MMAS-8.[@b45-ppa-12-2111],[@b47-ppa-12-2111] Hovinga et al used a 1-month recall period method to measure adherence.[@b48-ppa-12-2111] Two studies used a mixed-method approach using two items from the Epilepsy Self-Management Scale along with the MPR tool. MPR scores were determined using the participants' medication records in both these studies.[@b42-ppa-12-2111],[@b49-ppa-12-2111] MPR was determined by dividing the number of days on which medication was available by the number of days between the earliest prescription claims in the observation period through the end of the observation period with a threshold of \<0.80 defining non-adherence.[@b50-ppa-12-2111] The prevalence of non-adherence and methods of assessment across all the 13 studies have been listed in [Table 3](#t3-ppa-12-2111){ref-type="table"}.

### Factors associated with non-adherence

Factors associated with medication non-adherence across the 13 studies are outlined in [Table 4](#t4-ppa-12-2111){ref-type="table"}. In two studies, perceptions of barriers, lack of motivation to take medication, fear of adverse effects, and knowledge gap were reported to be the causes for medication non-adherence among PWE.[@b51-ppa-12-2111],[@b52-ppa-12-2111] Others factors such as difficulty in opening container lids or shortage of medication in the market were also reported to cause AED non-adherence.[@b51-ppa-12-2111],[@b53-ppa-12-2111]

### Patient-related factors

In four of the included studies, females were reported to be more likely to comply with AEDs.[@b44-ppa-12-2111],[@b45-ppa-12-2111],[@b48-ppa-12-2111],[@b49-ppa-12-2111] Depression and anxiety were associated with poor adherence in two studies.[@b45-ppa-12-2111],[@b47-ppa-12-2111] In one study, a significant difference in depression scores was reported between the low and the moderate-to-high adherence groups (*P*\<0.001).[@b45-ppa-12-2111] Four studies reported forgetfulness as the reason for AED non-adherence.[@b44-ppa-12-2111],[@b48-ppa-12-2111],[@b51-ppa-12-2111],[@b54-ppa-12-2111]

### Illness-related factors

Four studies investigated the associations between adherence and seizure control.[@b44-ppa-12-2111],[@b46-ppa-12-2111],[@b48-ppa-12-2111],[@b55-ppa-12-2111] Ferrari et al reported no significant association between seizure control and adherence to medication.[@b44-ppa-12-2111] Other three studies demonstrated a strong correlation between poor seizure control and non-adherence.[@b46-ppa-12-2111],[@b48-ppa-12-2111],[@b55-ppa-12-2111]

Medication-related factors
--------------------------

The most significant medication-related factors associated with non-adherence included missed doses, poly pharmacy, high cost, and medication side effects.[@b44-ppa-12-2111],[@b48-ppa-12-2111],[@b56-ppa-12-2111],[@b57-ppa-12-2111] In the study by Ferrari et al, 45% of patients who received mono therapy showed high treatment adherence while the rest showed moderate-to-low adherence.[@b44-ppa-12-2111] Nevertheless, Guo et al reported that non-adherence to AED had no significant association with mono/poly therapy (*P*\>0.05).[@b45-ppa-12-2111] AED unavailability (48%) was the major factor leading to non-adherence.[@b23-ppa-12-2111]

Physician-related factors
-------------------------

One study investigated the impact of the patient-physician relationship and found that trust in doctors was more prevalent among adherent patients (34%) compared to that in non-adherent patients (17%). Furthermore, adherent participants reported being comfortable while disclosing missed medications to their doctor (27% vs 12%).[@b48-ppa-12-2111] Other studies did not indicate the patient-physician relation and its impact on adherence.

### Impact of CAM on adherence and AED therapy

There seemed to be a deficiency of clinical evidence about AED non-adherence and CAM use. However, Durón et al assessed adherence to AEDs and CAM use and found non-adherence to AED in 121 patients, with the unavailability of AEDs (48%) being the most common reason for non-adherence and prayer, herbs, and potions being the common CAMs used as shown in [Table 5](#t5-ppa-12-2111){ref-type="table"}. Among 51.5% of CAM users, 44.2% reported that they had stopped taking their AEDs.[@b23-ppa-12-2111]

Quality of included studies
---------------------------

Quality varied across the studies included. The response rate varied from 11% to 79.5%. Nine studies did not report response rates.[@b28-ppa-12-2111],[@b31-ppa-12-2111],[@b33-ppa-12-2111],[@b39-ppa-12-2111],[@b40-ppa-12-2111],[@b46-ppa-12-2111],[@b47-ppa-12-2111],[@b56-ppa-12-2111],[@b58-ppa-12-2111] The manner in which par ticipants were recruited and the sample size was determined were not clearly reported in seven studies.[@b28-ppa-12-2111],[@b29-ppa-12-2111],[@b31-ppa-12-2111],[@b40-ppa-12-2111],[@b46-ppa-12-2111],[@b54-ppa-12-2111] Types of CAM used were not explained in two studies.[@b28-ppa-12-2111],[@b40-ppa-12-2111] Patients' adherence to medication was mostly assessed using the MMAS (n=6).[@b44-ppa-12-2111]--[@b47-ppa-12-2111],[@b56-ppa-12-2111],[@b57-ppa-12-2111] Three studies did not clearly explain how medication adherence was measured.[@b48-ppa-12-2111],[@b54-ppa-12-2111],[@b55-ppa-12-2111]

Discussion
==========

In the current study, we reviewed the use pattern and impact of CAM on AED adherence among PWE. We included 30 studies in this review and a particular concern was the low response rate in the included surveys. The variable methodological quality of many included studies is identified as a study limitation. Nine studies did not report the response rate. Further problems with surveys of CAM were related to the fact that no universally accepted definition of CAM exists. This means that different surveys monitor the use of different methods. Self-reported questionnaires typically provide overestimates of adherence for several reasons: first, they may rely on patients' own interpretation or memory of what advice was given and, if accepted, how closely it has been followed; and second, patients may tend to report higher levels of adherence in order to please health care providers or avoid embarrassment.[@b59-ppa-12-2111] CAM therapies for epilepsy in developing countries have evolved over the centuries, often in conjunction with the health care system, education level, and changing cultural beliefs.[@b40-ppa-12-2111] The use of CAM in developed countries was higher than that in developing countries, with some variation due to the difference in cultural and traditional norms.

The most prevalent types of CAM reported in the studies reviewed were the use of herbal products, prayer/spirituality, and yoga/exercise. Fear of AED-related side effects and poor seizure control were the most frequently reported reasons for using CAM. Although pharmacological treatments of epilepsy have been shown to be efficacious in mitigating various types of epilepsies, the side effects of these medications result in adverse effects on the patients' quality of life, often resulting in poor compliance.[@b57-ppa-12-2111] This is likely to contribute to a shift toward the use of CAM among PWE.[@b44-ppa-12-2111] Studies have shown that many PWE tend to concurrently use both CAM and antiepileptic medication. This may be due to attractive marketing strategies used by herbal and vitamin companies that make claims of the safety and benefits of CAM, which attract patients; however, there is limited scientific evidence of their efficacy and safety in epilepsy.[@b60-ppa-12-2111] Some studies have further shown that some PWE tend not to disclose their use of CAM to their health care providers working under the auspices of biomedical care.[@b48-ppa-12-2111]

In several countries, it is believed that epilepsy is linked to supernatural or spiritual causes, which may lead to under-treatment and greater reliance on CAM use.[@b26-ppa-12-2111],[@b40-ppa-12-2111],[@b61-ppa-12-2111] In these countries, it is believed that diseases caused by supernatural things cannot be cured with allopathic medicine and CAM should be used to treat such patients.[@b26-ppa-12-2111],[@b31-ppa-12-2111],[@b40-ppa-12-2111] Cultural views complicate the issue of medication non-adherence.[@b23-ppa-12-2111],[@b61-ppa-12-2111],[@b62-ppa-12-2111] Patients prefer CAM assuming that spirit possession is the cause of epilepsy and they seldom consider AEDs as the primary therapy.[@b23-ppa-12-2111] In many surveys, a significant percentage of PWE used CAM.[@b26-ppa-12-2111],[@b40-ppa-12-2111],[@b61-ppa-12-2111] Surveys conducted in multicultural regions show that vitamins, prayer for health, and stress management are the most frequently used types of CAM.[@b23-ppa-12-2111],[@b26-ppa-12-2111],[@b63-ppa-12-2111] Patients who associated epilepsy with non-biological causes, such as spirits and exorcism, often visited faith healers before going to a doctor which led to under-treatment and greater reliance on CAM usage.[@b34-ppa-12-2111] These findings indicate the need for educating people and spreading awareness regarding epilepsy and the role of AEDs in the treatment of epilepsy.[@b34-ppa-12-2111] However, there is no direct evidence from the reviewed literature that belief in the spiritual nature of epilepsy affects AED adherence. Further studies are needed to check the association of spiritual belief and AED adherence.

The prevalence of AED non-adherence was reported in 13 of the studies and ranged between 25% and 66%. However, the assessment methods used in these studies were mainly subjective (patient-reported questionnaires) and tended to overestimate patient adherence. Using a mixed-method approach (ie, using subjective and objective assessment tools), patient adherence can be more effectively estimated. Forgetfulness, specific beliefs about medications, depression, uncontrolled recent seizures, frequent medication dosage times and poly pharmacy were the most frequently reported factors associated with AED non-adherence. Similar findings were reported in a study where people using poly therapy were more likely to forget to take their medication.[@b70-ppa-12-2111]

Pharmacists should conduct counseling and educational programs to help patients improve medication adherence and change their false perception about the etiology of epilepsy. A study showed that the level of knowledge could possibly influence the levels of adherence to medications, and pharmacists could play a more active role in ensuring proper information is disseminated based on the education level of the patients.[@b64-ppa-12-2111] These findings are consistent with those of a study in which the compliance rate was high among patients with good knowledge about their disease.[@b65-ppa-12-2111] Furthermore, the use of various compliance aids such as pill boxes, medication reminders, and combination therapy (where possible) to reduce the number of pills can improve adherence.[@b66-ppa-12-2111] Since depression may reduce patients' adherence to medication, lower rates of depression may be associated with better medication adherence.[@b67-ppa-12-2111] Organizational religious activity had a significant positive association with adherence to medications and it can lower depression.[@b68-ppa-12-2111],[@b69-ppa-12-2111]

Although many studies have reported the reasons for CAM usage among PWE, there seemed to be limited evidence on AED non-adherence due to CAM usage.[@b23-ppa-12-2111] Among the 30 studies included in this review, the association between AED adherence and CAM use was assessed in only one study.[@b23-ppa-12-2111] More studies should be performed to investigate the resultant effects of CAM use by PWE to gather detailed information on whether the treatment under consideration has a positive or negative impact on the patient's health condition and adherence to AED.

Conclusion
==========

Medication non-adherence is associated with forgetfulness, shortage of medication, cultural beliefs, and the use of CAMs instead of AEDs. An intensive education program should be the priority for changing patients' beliefs. Awareness should be raised regarding the etiology of epilepsy and effectiveness of AEDs in treating epilepsy. Governments and pharmaceutical industries need to collaborate to access, obtain, store, and distribute AEDs effectively. Moreover, further studies are needed to investigate the effects of CAM in epilepsy and its impact on medication adherence, to provide insight into whether or not the treatments being used are beneficial since the studies comparing the impact of CAM on adherence and AED therapy are limited.
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###### 

Criteria for inclusion and exclusion of studies in the review

  ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Population                Epilepsy patients aged 18 and above
  ------------------------- -------------------------------------------------------------------------------------------------------------------------------------------------
  Phenomenon of interest    The phenomenon of interest included\
                            • Use of CAM in developed and developing countries\
                            • Types and reasons of CAM usage\
                            • Adherence to AED

  Primary outcome measure   The outcome measures of interest included but were not restricted to the following:\
                            • Prevalence and types of CAM usage\
                            • Prevalence of adherence and method of assessment\
                            • Factors associated to medication non-adherence\
                            • Impact of CAM on adherence and AED therapy

  Types of studies          Quantitative cross-sectional surveys and qualitative studies. Studies were included if they reported one or more of the outcomes detailed above
  ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------

**Abbreviations:** CAM, complementary and alternative medicine; AED, antiepileptic drug.

###### 

Prevalence and types of CAM use

  No     Authors/type of study                                       Type of population   Country          Year   \% of CAM usage   Types of CAM used                                                                                 Mind and body practice   Natural products   Alternative/traditional medicine
  ------ ----------------------------------------------------------- -------------------- ---------------- ------ ----------------- ------------------------------------------------------------------------------------------------- ------------------------ ------------------ ----------------------------------
                                                                                                                                                                                                                                                                                  
  1\.    Szabo[@b71-ppa-12-2111] survey                              Epilepsy N=341       USA              2003   50%               The most helpful were stress reduction, yoga, and botanicals (herbs)                              √                        √                  --
  2\.    Al Asmi et al[@b34-ppa-12-2111] cross-sectional             Epilepsy N=101       Oman             2013   73.3%             Wearing (amulet) 73% Herbal 47%                                                                   √                        √                  --
  3\.    Mcconnell et al[@b27-ppa-12-2111] survey                    Epilepsy N=120       USA              2014   70%               Prayer/spirituality (31%), meditation (19%), vitamins (19%), and stressmanagement (16%)           √                        √                  --
  4\.    Liow et al[@b26-ppa-12-2111] survey                         Epilepsy N=228       USA              2007   25%               Prayer/spirituality (46%), vitamins (25%), chiropractic care (24%), and stress management (16%)   √                        √                  --
  5\.    Easterford et al[@b28-ppa-12-2111] survey                   Epilepsy N=400       UK               2005   34.6%             --                                                                                                --                       --                 --
  6\.    Kim et al[@b40-ppa-12-2111] structured interviews           Epilepsy N=246       Korea            2006   31.3%             --                                                                                                --                       --                 --
  7\.    Tandon et al[@b35-ppa-12-2111] patient interview            Epilepsy N=1,000     India            2002   32%               Ayurvedic (43%) homeopathy (12.5%)                                                                --                       √                  √
  8\.    Kuan et al[@b39-ppa-12-2111] interviews                     Epilepsy N=403       Taiwan           2011   49.1%             Traditional Chinese medicine (51.5%) and temple worship (48.0%)                                   √                        --                 √
  9\.    Sirven et al[@b8-ppa-12-2111] survey (email)                Epilepsy N=425       USA              2003   44%               Stress reduction (68%), yoga (57%), and botanicals (55%)                                          √                        √                  --
  10\.   Harms et al[@b30-ppa-12-2111] pharmaco-epidemiology study   Epilepsy N=??        USA              2006   23%               Ginkgo accounted for 61.9% among epilepsy patients                                                --                       √                  --
  11\.   Peebles et al[@b29-ppa-12-2111] survey                      Epilepsy N=150       USA (Columbus)   2000   24%               Massage (50%) and herbs/supplements (41%) were used the most                                      √                        √                  --
  12\.   Asadi-Pooya and Emami[@b33-ppa-12-2111] cross-sectional     Epilepsy N=158       Iran             2014   14.5%             Herbal drugs, traditional medicine and exercise                                                   √                        √                  √
  13\.   Bhalerao et al[@b36-ppa-12-2111] survey                     Epilepsy n=150       India            2013   7.7%              Ayurveda 46%, homeopathy 22%, yoga 22%                                                            √                        --                 √
  14\.   Naveen et al[@b37-ppa-12-2111] cross-sectional              Epilepsy N=300       India            2013   28.7%             Ayurveda (26.7%), yoga (25.6%) homeopathy (16.3%), folk medicine (29.1%)                          √                        √                  √
  15\.   Razali and Yassin[@b32-ppa-12-2111] survey                  Epilepsy N=60        Malaysia         2008   26.7%             Traditional healers (bomoh) and homeopathic practitioners                                         --                       √                  √
  16\.   Pal et al[@b31-ppa-12-2111] interview                       Epilepsy N=400       India            2008   7.5%              Faith healers, amulets, massage                                                                   √                        √                  --

**Note:** -- indicates that this category of CAM was not reported in the study.

**Abbreviation:** CAM, complementary and alternative medicine.

###### 

Prevalence of adherence and methods of assessment

  No     Authors/type of study                                     Type of population   Country     Year   Prevalence of non-adherence   Method of assessment
  ------ --------------------------------------------------------- -------------------- ----------- ------ ----------------------------- ----------------------------------------
                                                                                                                                         
  1\.    Chesaniuk et al[@b58-ppa-12-2111] internet based survey   Epilepsy N=140       USA         2014   25%                           Knobel brief adherence questionnaire
  2\.    Sweileh et al[@b57-ppa-12-2111] cross-sectional           Epilepsy N=75        Palestine   2011   64%                           MMAS
  3\.    Hovinga et al[@b48-ppa-12-2111] cross-sectional           Epilepsy N=408       USA         2008   29%                           --
  4\.    Paschal et al[@b54-ppa-12-2111] cross-sectional           Epilepsy N=180       USA         2014   30%                           Self-reported questionnaire
  5\.    Chapman et al[@b42-ppa-12-2111] cross-sectional           Epilepsy N=438       UK          2014   37%                           Epilepsy Self-Management Scale and MPR
  6\.    Ferrari et al[@b44-ppa-12-2111] cross-sectional           Epilepsy N=385       Brazil      2013   66%                           Morisky green scale
  7\.    Jones et al[@b46-ppa-12-2111] cross-sectional             Epilepsy N=54        UK          2006   59%                           MMAS-4
  8\.    Guo et al[@b45-ppa-12-2111] survey                        Epilepsy N=184       China       2015   40%                           MMAS-8
  9\.    Shallcross et al[@b47-ppa-12-2111] cross-sectional        Epilepsy N=55        USA         2015   36%                           MMAS-8
  10\.   Smithson et al[@b49-ppa-12-2111] survey                   Epilepsy N=438       UK          2013   30%                           Self-reported questionnaire and MPR
  11\.   Molugulu et al[@b55-ppa-12-2111] cross-sectional          Epilepsy N=272       Malaysia    2016   49%                           Patient administered questionnaire
  12\.   Nakhutina et al[@b51-ppa-12-2111] cross-sectional         Epilepsy N=72        USA         2011   63%                           MMAS-4
  13\.   Zeber et al[@b56-ppa-12-2111] survey                      Epilepsy N=6,373     USA         2010   48%                           MPR

**Note:** -- indicates method of adherence assessment was not revealed in this study.

**Abbreviations:** MMAS, Morisky Medication Adherence Scale; MPR, medication possession ratio.

###### 

Factors associated with medication non-adherence

  No                                          Authors/type of study                                     Country                  Patient-related factors (socio-economic, perceptions and beliefs)   Illness-related factors (severity of illness and frequency of symptoms)   Medication-related factors (number of daily doses, efficacy, and side effects), cost   Physician-related factors (patient-physician relationship)
  ------------------------------------------- --------------------------------------------------------- ------------------------ ------------------------------------------------------------------- ------------------------------------------------------------------------- -------------------------------------------------------------------------------------- ------------------------------------------------------------
                                                                                                                                                                                                                                                                                                                                                                      
  1\.                                         Chesaniuk et al[@b58-ppa-12-2111] internet based survey   USA                      √                                                                   --                                                                        --                                                                                     --
  Higher perceived epilepsy- related stigma                                                                                                                                                                                                                                                                                                                           
  2\.                                         Jones et al[@b46-ppa-12-2111] cross-sectional             UK                       --                                                                  √                                                                         --                                                                                     --
  Poor seizure control                                                                                                                                                                                                                                                                                                                                                
  3\.                                         Sweileh et al[@b57-ppa-12-2111] cross-sectional           Palestine                √                                                                   --                                                                        √                                                                                      --
  Stress 41%                                                                                            Missed dose 13%                                                                                                                                                                                                                                               
  4\.                                         Hovinga et al[@b48-ppa-12-2111] cross-sectional           USA                      √                                                                   √                                                                         √                                                                                      √
  Forgetfulness 72%                           Poor seizure control                                      Cost 13%                                                                                                                                                                                                                                                      
                                              Side effects 9%                                                                                                                                                                                                                                                                                                         
  5\.                                         Paschal et al[@b54-ppa-12-2111] cross-sectional           USA                      √                                                                   --                                                                        √                                                                                      --
  Forgetfulness 68%                                                                                                                                                                                                                                                                                                                                                   
  6\.                                         Chapman et al[@b42-ppa-12-2111] cross-sectional           UK                       √                                                                   --                                                                        --                                                                                     --
  Negative perception of                                                                                                                                                                                                                                                                                                                                              
  AED (36.4%)                                                                                                                                                                                                                                                                                                                                                         
  7\.                                         Ferrari et al[@b44-ppa-12-2111] cross-sectional           Brazil                   √                                                                   √ Worsening symptoms                                                      √                                                                                      --
  Forgetfulness (47.5%)                       (9.0%)                                                    Poly pharmacy 66%,                                                                                                                                                                                                                                            
  Lack of time (39.2%)                                                                                                                                                                                                                                                                                                                                                
  8\.                                         Guo et al[@b45-ppa-12-2111] cross-sectional               China                    √                                                                   --                                                                        --                                                                                     --
  Depression, anxiety                                                                                                                                                                                                                                                                                                                                                 
  9\.                                         Shallcross et al[@b47-ppa-12-2111] cross-sectional        USA                      √                                                                   --                                                                        --                                                                                     --
  Depression (21%)                                                                                                                                                                                                                                                                                                                                                    
  10\.                                        Molugulu et al[@b55-ppa-12-2111] cross-sectional          Malaysia                 √                                                                   √                                                                         √                                                                                      --
  Patient understanding                       Seizure frequency                                                                                                                                                                                                                                                                                                       
  11\.                                        Nakhutina et al[@b51-ppa-12-2111] cross-sectional         USA                      √                                                                   --                                                                        --                                                                                     --
  Forgetfulness                                                                                                                                                                                                                                                                                                                                                       
  beliefs about medicines                                                                                                                                                                                                                                                                                                                                             
  12\.                                        Zeber et al[@b56-ppa-12-2111] survey                      USA                      --                                                                  --                                                                        √                                                                                      --
                                                                                                        Side effects                                                                                                                                                                                                                                                  
  13\.                                        Durón et al[@b23-ppa-12-2111] observational study         USA                      √                                                                   --                                                                        √                                                                                      --
  Forgetfulness 13.2%                                                                                   AED unavailability 48%                                                                                                                                                                                                                                        

**Note:** -- indicates that this category of factor was not reported in this study.

**Abbreviation:** AED, antiepileptic drug.

###### 

CAM usage and adherence among epilepsy patients

  No    Authors/type of study                               Type of population       Country           Year   Prevalence of adherence   \% of CAM usage   Types of CAM used                    Mind and body practices   Natural products   Alternative/traditional medicine
  ----- --------------------------------------------------- ------------------------ ----------------- ------ ------------------------- ----------------- ------------------------------------ ------------------------- ------------------ ----------------------------------
  1\.   Durón et al[@b23-ppa-12-2111] observational study   Epilepsy patient N=274   Central America   2009   55.8%                     51.5%             Prayer, herbs, potions and massage   √                         √                  √

**Abbreviation:** CAM, complementary and alternative medicine.
